ロード中...
BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance
Systemic sclerosis (SSc) is an autoimmune disease characterized by skin and lung fibrosis. More than 90% of patients with SSc are positive for autoantibodies. In addition, serum B cell activating factor (BAFF) level is correlated with SSc severity and activity. Thus, B cells are considered to play a...
保存先:
| 出版年: | Sci Adv |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Association for the Advancement of Science
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6040844/ https://ncbi.nlm.nih.gov/pubmed/30009261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.aas9944 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|